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The aim of this short review was to discuss applications of a unique biopolymer chitosan in practical medicine, 
especially for bone tissue engineering. The article highlights the preparation and properties of innovative chi-
tosan-based biomaterials such as CaP-chitosan (CS-CP)-composites and chitosan-alginate (CS-AG)-scaffolds. 
This paper takes a closer look at the physicochemical properties, spectral characteristics and chemical modifi-
cations of the chitosan molecule. The obtained chitosan-apatite composites were analysed using X-ray diffrac-
tion to verify the crystalline nature of their structures. It was observed that the addition of chitosan to the 
composite material reduces  apatite crystallinity. Besides, an accent was made on antibacterial properties of 
chitosan, the use of chitosan nanoparticles to produce nanofibers and controlled drug delivery systems.
K e y w o r d s: chitosan, hydroxyapatite, biocomposites, X-ray diffraction.
Introduction
Over the last years, chitosan (CS) has attracted a 
great interest of scientists as functional polymeric 
material because of its remarkable intrinsic proper-
ties: biodegradability, biocompatibility, nontoxicity, 
antibacterial activity, mucoadhesive, analgesic and 
haemostatic properties [1–3]. Chitosan is a linear, 
semi-crystalline polysaccharide composed of 
(1→4)-2-acetamido-2-deoxy-β-D-glucan (N-acetyl 
D-glucosamine) and (1→4)-2-amino-2-deoxy-β-D-
glucan (D-glucosamine) units [1, 4–6]. Chitosan can 
be easily obtained from a natural polymer chitin af-
ter its partial deacetylation by chemical hydrolysis 
under severe alkaline conditions or by enzymatic 
hydrolysis [7, 8]. Chitosan is well tolerated by living 
tissues, including the skin, ocular membranes, the 
nasal epithelium. A low or no toxicity of chitosan 
compared with other natural polysaccharides has 
been demonstrated by in vivo toxicity studies [9]. 
Some studies showed that chitosan, as an immune 
adjuvant, could effectively promote the local im-
mune response and enhance antigen presentation 
[10]. The combination of CS with different materi-
als, such as hydroxyapatite (HA), is very promising, 
especially for orthopedics and traumatology [11]. 
All these features make chitosan an outstanding can-
didate for biomedical applications. 
Physical and chemical properties of chitosan 
Chitosan as the product of partial deacetylation of 
chitin contains five types of active functional groups: 
primary amine groups at the C-2 position of each 
deacetylated structural unit, secondary amide groups, 
ether groups of polysaccharide main chain as well as 
both primary and secondary hydroxyl groups at the 
C-6 and C-3 positions, respectively (Fig. 1).
The molecular weight (MW) of CS is in the range 
of 300 to 1 000 kDа and it depends on the source and 
the method used for obtaining CS. Degree of CS 
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deacetylation (DD) (N- acetylglucosamine / glucos-
amine) may vary from 30 to 95 %. The higher DD of 
CS, the greater the quantity of protonated amino 
groups in the polymer and, correspondingly, the 
higher the amount of charge on the macromolecule. 
In crystalline form, CS is insoluble in aqueous solu-
tions with pH > 7 whereas in dilute acids (pH < 6) it 
becomes soluble due to protonation of NH2-
groups [5]. Chitosan’s primary amines confer impor-
tant material properties. At low pH, the amines are 
protonated making chitosan a cationic polyelectro-
lyte. In protonated form, the amines allow connection 
through electrostatic interactions [12]. Due to its 
amino groups, chitosan can form bonds with a wide 
variety of organic and inorganic molecules, such as 
lipids, proteins, DNA and some negatively charged 
synthetic polymers [13–16]. At high pH, the amines 
are deprotonated and chitosan undergoes a transition 
from a soluble cationic polyelectrolyte to an insolu-
ble polymer. Insolubility of chitosan in water means 
that the intermolecular interactions between macro-
molecules exceed the interactions in the system of 
“chitosan-water molecules”. Importantly, this pH-re-
sponsive switch is near neutrality (chitosan’s appar-
ent pKa has been reported to range between 6 and 7) 
[17, 18] suggesting chitosan as a biologically-derived 
A
     
B
Fig. 1. The structural formula of chitin (A) and chitosan (B)
Fig. 2. Schematic representation of the metal-chitosan complexation [22]
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stimuli-responsive polymer for medical applications 
(e.g., injectable matrices) [19]. There are well known 
the nucleophilic properties of the amines that allow 
connections through covalent linkages that can be 
formed through a range of coupling chemistries [20]. 
Chitosan’s metal binding properties [21] allow con-
nections through chelation mecha nisms. Fig. 2 illus-
trates the structural chemical formula of two strands 
of chitosan and the “cross-linking” mechanism 
caused by the divalent metal ion [22].
Micro/nanoparticles and hydrogels are widely 
used in the design of chitosan-based therapeutic sys-
tems [4]. The cationic nature of CS provides the 
electrostatic interaction with quantivalent linear an-
ionic polysaccharides (glycosaminoglycans (GAG), 
proteoglycans etc.). This factor is very important be-
cause of a large number of growth factors and other 
proteins bound to GAG, that is why the formation of 
GAG-CS complexes provides maintenance and ac-
cumulation of these necessary biopolymers in vivo. 
Thus, chitosan based scaffolds deliver growth fac-
tors in a controlled fashion to promote the in-growth 
and biosynthetic ability of chondrocytes [4]. Under 
the action of cellular enzymes, especially lysozyme, 
CS degraded depending on the degree of crystallini-
ty and deacetylation [6]. Hence these properties 
must be necessarily taken into account at creating 
chitosan based implants. Also it should be noted that 
the CS hydrogel composite is able to form a porous 
structure using, for example, lyophilization techno-
logy (“freeze-drying”). A pore size in the CS hydro-
gel composite depends on speed of freezing. The 
degree of porosity and pore orientation significantly 
affect the mechanical properties of the implant. 
Another property of CS is its internal antibacterial 
ability [23–25]. 
Chitosan in bone tissue engineering
Tissue engineering (TE) is an interdisciplinary area 
that contains both a basic knowledge of life sciences 
and engineering to create biologically compatible, 
biodegradable scaffolds (matrices) in different forms 
(powder, microcapsules, gels, films, etc.) for a wide 
use in nanomedicine. Systems for the controlled 
drug delivery by using chitosan and its derivatives 
are of huge interest [4]. Chitosan is widely used in 
bone tissue engineering because of its ability to pro-
mote a cell growth and the formation of mineral ma-
trix by osteoblasts [26]. Biocompatibility of chitosan 
minimizes the local inflammation, and its conver-
sion into a porous structure contributes to osteocon-
ductivity [27]. The Chitosan - Calcium Phosphate 
composites (CS-CP) were the subject of intensive 
study in the world [28–31]. 
CS-CP composites
Biomaterials that mimic the structure and composi-
tion of bone tissues at the nanoscale level are ex-
tremely important for the development of bone tis-
sue engineering applications [32]. CS-CP compo si-
tes have certain advantages compared to other simi-
lar structures. Thus, during the resorption, the degra-
dation products of chitosan and calcium phosphate 
(calcium ions, phosphates, glycosamines, etc.) are 
naturally metabolized and do not induce the increas-
ing calcium and phosphorus concentrations in urine, 
serum or internal organs. A composite material con-
tains both the macro- and micropores and nano-sized 
crystals of HA. This promotes an increase in the re-
active surface and material osteoconductive activity. 
Similar 3D-macroporous ceramics pierced by chito-
san grid have better mechanical properties [33, 34]; 
therefore, there is a perspective of the CS-CP com-
posites future use in the clinic. The main advantages 
of CS-CP biomaterials are: structural organization, 
which is close to the structure of natural bone, bio-
compatibility, biodegradation, macro- and micropo-
rosity, regulation of resorption rate, immobilization 
of drugs, antibacterial action, simplicity of flowsheet 
synthesis, low cost. 
Among a wide range of calcium phosphates hy-
droxyapatite (HA), Ca10(PO4)6(OH)2 is a widely 
used material for biomedical application in dentistry 
and orthopedy due to the excellent bioactivity, bio-
compatibility and osteoconductivity [31, 35]. 
However, the migration of HA powder from im-
planted sites and bone defects is really a big prob-
lem. Therefore, organic compounds in nanocompo-
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sites are promising for improving weak mechanical 
properties of HA [36].
The CS-HA composites have been recently syn-
thesized in our laboratory. For this aim the chitosan 
macromolecules ( MW 500 kDa, 200 kDa, 39 kDa) 
with DD 85 % were supplied by the “Bioprogress” 
(Moskow, Russia). Calcium acetate Ca(CH3COO)2, 
sodium dihydrogen phosphate NaH2PO4, and sodi-
um hydroxide (NaOH) were of analytical grade and 
supplied by “Merck”. An influence of the chitosan’s 
molecular weight and various ways of the synthesis 
on obtaining the CS-HA composite structure have 
been studied. Calcium acetate was used as the 
0.167 M solution in 1 % CH3COOH (first way of 
synthesis) or was added in solid state to chitosan so-
lution in 1 % CH3COOH (second way of synthesis).
By the first way of synthesis 0.8 g of chitosan 
powder with certain MW were added to 20 mL of the 
0.167 M (CH3COO)2Ca stock solution in 1 w % 
CH3COOH. The final chitosan concentration in the 
reaction mixture was 0.4 w %. The calcium acetate–
chitosan solution was stirred in a shaker (160 rpm) 
for 1.5 h at 37 ºC, then 20 mL of 0.1 M NaH2PO4 
solution were added gradually to the above mixture. 
The pH value was adjusted to 11.8 by using 10 M 
NaOH solution. The obtained suspension was aged 
for 5 days at 22 ºC, then washed thoroughly with 
deionized water to pH 7.4. Finally, the precipitate 
was separated by centrifuging the suspension. For 
the analysis the product was dried at 37 oC and an-
nealed for 1 h at 900 oC. The second way of synthesis 
was provided by addition of solid (CH3COO)2Ca 
(0.526 g) to the 20 mL of the 0.4 w % chitosan solu-
tion in 1 % CH3COOH. The calcium acetate–chito-
san solution was stirred in a shaker (160 rpm) for 
1.5 h at 37 ºC, after which 20 mL of 0.1 M NaH2PO4 
solution were added gradually to the above mixture. 
The pH value of solution (about 11.0) was corrected 
by using 10 M NaOH solution. A white precipitate 
was observed after the phosphate solution addition 
at both ways of synthesis. It was associated with the 
hydroxyapatite formation. Both suspensions were 
aged for 5 days at 22 ºC, then washed thoroughly 
with deionized water to obtain solution of pH 7.4. 
Finally, the precipitate was separated by centrifug-
ing the suspension. For the analysis the product was 
dried at 37 oC and annealed for 1 h at 900 oC. The 
Obtained composites consisted of 80 w % of HA and 
20 w % of CS. 
The crystallinity and structure of precipitates were 
examined using an X-ray diffractometer DRON-3 
(“Burevestnik”, Russia) connected to a computer-
aided system for the experiment control and data 
processing. The Ni-filtered CuKα radiation (wave-
length 0.154 nm) with a conventional Bragg–
Brentano θ-2θ geometry was used. The current and 
voltage of X-ray tube were 20 mA and 40 kV respec-
tively. The samples were tested in a continuous mode 
in the range 10º to 60º at a rate 2.0 º/min with 
2θ-angles. The samples phase composition was de-
termined and crystallite size calculated. The average 
crystallite size (L) and strain (ε) were calculated in 
the [0 0 c] crystal direction using XRD data by 
Scherrer equation [37]. The crystalline phases were 
identified by comparing the experimental XRD pat-
terns to the standards compiled by the Joint 
Committee on Powder Diffraction and Standards 
(JCPDS cards). The formation of crystalline HA 
phase occurs in both the presence and the absence of 
polymer, independently from chitosan MW and syn-
thesis way. The existence of 2θ peaks at approxi-
mately 26º, and 31.9º corresponding to the (002) and 
(211) diffraction planes confirms the formation of 
HA phase in products [36]. Taking into account the 
broadening of each peak in XRD spectra, mean crys-
tallite sizes for examined samples were calculated 
using Scherrer equation and approximation method 
(Table 1).
As can be assumed from the Table 1, 20 w % of 
chitosan in material composition did not decrease 
significantly crystallite sizes of HA-CS samples 
compared to HA sample. The changes in the polymer 
molecular weight and the way of synthesis had no 
observable effect on the peaks positions and/or their 
intensity. However, the strain in [0 0 c] direction in-
creased for all HA-CS composite samples indicating 
significant defects in the hydroxyapatite crystal struc-
ture caused by the presence of the polymer. 
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To evaluate the functional groups of CS, HA and 
synthesized composite HA-CS (Fig. 3), the FTIR 
analysis was performed by the instrument “Thermo 
Nicolet Nexus 470 ESP” (Minsk Technological 
University, Belarus). The sample for spectral analy-
sis was prepared in a traditional way: a small amount 
of the preparation (synthesized composite powder) 
was mixed with KBr in the ratio 1:200 in an agate 
mortar while grinding. From the obtained mixtures 
corresponding tablets were prepared in press-forms 
of stainless steel under hydraulic pressure. 
Transmission spectrum was obtained in the frequen-
cy range of 400–5000 cm–1 with a spectral resolution 
of 0.125 cm–1.
FTIR-spectrum of CS(c) shows characteristic 
peaks of amide I at 1651 cm−1 (–C=O stretching), 
amide III at 1378 cm–1 (C– N stretching coupled 
with NH in plane deformation), CH2 wagging cou-
pled with OH in plane deformation at 1324 cm−1. 
The peak at 1598 cm–1 belongs to the bending vibra-
Table 1. Structure characteristics of hydroxyapatite 
nanocrystals in dried at 37 °C HA-CS nanocomposites
Sample Miller Indices
Crystallite 
sizes by 
Scherrer, nm
Approximation method
Crystallite 
sizes, nm
Strain, 
∙103
HA
(0 0 2) 22.8
22.8 0.003
(0 0 4) 22.8
HA / CS 
500 (1)
(0 0 2) 21.7
21.5 0.097
(0 0 4) 22
HA / CS 
500 (2)
(0 0 2) 19.6
21.4 0.71
(0 0 4) 18.2
HA / CS 
200 (1)
(0 0 2) 18.3
17.8 0.27
(0 0 4) 19
HA / CS 
200 (2)
(0 0 2) 19
18.4 0.32
(0 0 4) 19.7
HA / CS 
39 (1)
(0 0 2) 18.2
21.7 1.53
(0 0 4) 15.6
HA / CS 
39 (2)
(0 0 2) 21.6
20.7 0.342
(0 0 4) 22.6
Fig. 3. FTIR-spectra of a) HA-CS nanocomposite (down), b) HA, sintered at 900 ºC (middle), c) CS with MW 500 kDa (top)
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tions of the N–H and C–N (amide II band). Peaks at 
1430 belong to the N–H stretching of the amide and 
ether bonds [38]. The vibration band about 
1029 cm−1 – 1077 cm−1 indicates the C–O stretching 
vibration in the primary and secondary hydroxyl 
groups in chitosan [39, 40], wide band (3429 cm–1) 
is attributed to –OH stretching and –NH2 asymmet-
ric stretching vibrations [41], the peak at 2868 cm–1 
is caused by –CH2-stretching vibrations [42].
FTIR-spectrum of CS (c) shows characteristic 
bands of amide I (the main contribution of C=O 
stretching) at 1651 cm–1 and amide II (the main con-
tribution of N–H bending) together with N–H bend-
ing vibration of primary amine groups at 1598 cm–1. 
Three bands at ~1450, 1430 and 1378 cm–1 belong to 
C-H asymmetric and symmetric bending vibrations 
of methyl and methylene groups. The band of –CH2- 
wagging coupled with -OH in plane deformation ap-
pears at 1324 cm–1. Some vibration bands in a region 
of 1200–1000 cm–1 with the main peak at 1161 cm–1 
indicate asymmetric and symmetric C–O–C and 
C–O stretching vibrations of CS ether and hydroxyl 
groups. The O–H and N–H stretching vibrations of 
hydroxyl, amide and amine groups of CS appear in 
FTIR spectrum by a wide band with maximum at 
3429 cm–1, whereas C-H stretching of –CH2- and –
CH3 groups is revealed by two overlapped bands at 
2920 and 2862 cm–1. 
Pure HA (b) shows a vibration band around 
3427 cm–1 and peak at 630 cm–1 corresponding to 
stretching vibration of the hydroxyl group [43]. The 
characteristic peaks at 576 cm–1, 604 cm–1, 961 cm–1, 
1048 cm–1and 1090 cm–1 are due to the bending and 
stretching modes of P–O vibrations in the phosphate 
network [44, 45]. 
In the HA-CS spectrum (a) the protonation of chi-
tosan amine functionalities is suggested by the pres-
ence of the band, attributed to NH3+ groups, namely 
the bending vibration at 1475 cm−1. This is evidently 
conditioned by the formation of electrostatic bonds 
with HA. Also the low-frequency shift of the amide 
I band up to 1638 cm–1 is observed, thus pointing out 
the participation of carbonyls of CS amide groups in 
hydrogen bonding with hydroxyl groups of HA. It 
was observed the disappearance of the vibration 
band in HA-CS spectrum (a) at 1324 cm−1 that may 
indicate partial phosphorylation of hydroxyl groups 
in CS with the feather formation of calcium phos-
phates. The wide band indicated the C–O–C and 
C–O stretching vibrations in the ether; the primary 
and secondary hydroxyl groups in CS spectrum (c) 
were present as the vibration band with peak at 
1032 cm–1 in the spectrum of HA–CS (a). These 
changes may be attributed to the formation of hydro-
gen bonds with participation of ether and/or –OH- 
groups in HA and CS. Additionally, the vibration 
bands at 960 cm–1 and 630 cm–1, belonging to the 
phosphate- and hydroxyl- groups in HA (b) were ab-
sent in the HA–CS spectrum. All these facts confirm 
molecular interactions between CS and HA in the 
HA–CS composite.
Chitosan-alginate-hydroxyapatite polyelec-
trolyte composites
The chitosan- and sodium alginate (AG)-based scaf-
folds have been widely used as biomaterials in tissue 
engineering. Freeze-drying, also known as lyophili-
zation, has been used for the fabrication of polymer-
based hydrogels. The porous scaffolds composed of 
AG and CS have been fabricated by the formation of 
a polyelectrolyte complex (PEC) between macro-
molecules of both polymers [46]. They perform a 
3D-grid with uniformly distributed and intercon-
nected pores. Two technologies of the scaffold for-
mation are proposed in this paper. According to the 
first, the uncrosslinked alginate scaffold is formed 
from 4 w % AG solution using the “freeze-drying” 
technology. Next, it undergoes some crosslinking 
using 1 w % CaCl2. By the second technology, the 
alginate scaffold was immerged into 2 w % CS solu-
tion or the CS-HA composite acetic acid aqueous 
solution. In this case the pores of the alginate scaf-
folds were filled with chitosan solution. These sam-
ples were frozen at –40 °C and lyophilized. Finally, 
the samples were additionally crosslinked with 
CaCl2 solution.
Chitosan-alginate (CS-AG)-scaffolds exhibit bet-
ter mechanical properties and thermostability than 
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AG-scaffold, crosslinked with calcium ions only. 
The main reasons for the mechanical strength im-
provement of crosslinked scaffold could be strong 
ionic interactions. In the Ca2+ crosslinked AG scaf-
fold the mechanical strength is enhanced because 
Ca2+ is characterized by strong ionic interaction with 
COO- in an alginate chain. For CS-AG PEC scaffold 
the strong interaction exists between NH3+ groups in 
CS and COO- groups in alginate (Fig. 4). Additionally, 
a decrease of porosity for crosslinked scaffold is an-
other factor enhancing the mechanical strength. 
Considering the participation of chitosan in PEC, 
it should be noted a series of studies of chitosan 
complexes with DNA, glycosaminoglycans, chon-
droitin sulfate, hyaluronic acid, heparin, carboxy-
methyl cellulose, pectin and proteins such as gelatin, 
albumin, collagen and keratin [47–52]. The stability 
of such complexes depends on the charge density, 
solvent, ionic strength, pH and temperature [46]. 
The Chitosan-, alginate- and hydroxyapatite-based 
scaffolds (with a ratio of 1:1:1) were recently syn-
thesized in our laboratory using our own flowsheet. 
Such precursors were used for the synthesis: chito-
san (MW 500 kDa, DD 80%, “Bioprogress”, 
Moscow), sodium alginate (E401), sodium hydro-
gen phosphate (Na2HPO4) and calcium acetate 
(CH3COO)2Ca∙H2O (China). 500 ml of chitosan so-
lution (2 g/l in 1 w % acetic acid) were gradually 
added to 0.1 M calcium acetate (100 ml); 1 g of so-
dium alginate powder was dissolved in 0.1 M sodi-
um hydrogen phosphate (60 ml). Two obtained solu-
tions were mixed and stirred in a shaker (160 rpm) at 
37 ºC for 5 h. pH was adjusted with 10 M NaOH 
solution to 11.0. Additionally the mixture was stirred 
by ultrasound, heated at 80 ºC for 10 min and aged 
for 48 h for the HA nucleation. The obtained product 
was washed with the deionized water to pH 7.0-7.4 
with subsequent freezing and vacuum drying 
(“freeze-drying”) at –150 °C during 16 h. As a result, 
the porous HA-CS-AG-scaffold with a ratio of com-
ponents 1:1:1 was obtained. The polymer amounts 
for the synthesis might be calculated to obtain the 
product with required component proportions. The 
cation-anionic interactions between macromolecules 
of CS and AG are the main driving force in the cre-
ation and stabilization of the biopolymer scaf-
folds [31].
X-ray structure analysis of apatite-biopoly-
mer composites
Recently the usage of materials in the form of hydro-
gels has become increasingly popular. The structure 
of the polymer chains that form a three-dimensional 
net of gel enables immobilization and sufficient con-
tent of water, biological fluids or drugs [53, 54]. We 
investigated the composite materials that consisted 
of the polymer matrix and inorganic filler and to 
some extent modeled a bone. As the polymer matrix, 
chitosan was used in the sample 1 and sodium algi-
nate - in the sample 2.
Fig. 4. Chemical structures of CS (top) and AG (down) and the scheme of their interaction
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Sample N 1: HA–CS composite. The HA–CS 
composite was synthesized by wet chemistry. Two 
solutions were prepared for the synthesis: 1) 100 mL 
[of] 0.1 M CaCl2, pH was adjusted up to 11.0 by ad-
dition of 10 M NaOH solution; 2) chitosan (MW 39 
kDa) was dissolved in 100 ml of 0.06 M H3PO4 in 
the amount, which provides chitosan concentration 
in the final material from 10 to 40 w %. The second 
solution was added drop by drop to the first one fol-
lowed with mixing and heating at 60 °C during 
10 min. The pH value was adjusted by NaOH addi-
tion to 7.4. After aging for 24 h the resulting suspen-
sion was washed with distilled water and centri-
fuged. The degree of moisture in the obtained gel 
ranged from 70 to 88 w %. The composition of sol-
ids was: HA from 60 to 90 w %, CS from 10 to 
40 w %. For analysis, the composites were dried at 
37 °C and annealed for 1 h at 900 ºC .
Sample N 2: HA–AG composite. Orthophosphoric 
acid H3PO4 (0.06 M), anhydrous calcium chloride 
CaCl2 (0.1 M), aqueous solution of sodium hydrox-
ide NaOH (10 M) and sodium alginate (E401, MW 
15 kDa, China) were used as starting materials for the 
HA-AG composite preparation. The composite mate-
rial was synthesized by the “wet chemistry” method: 
1) sodium alginate was dissolved in 100 ml of 0.06 M 
H3PO4 in the amount, which provides its content in 
the final material from 10 to 40 w % at 37 °C. This 
solution was added drop by drop to the calcium chlo-
ride solution with vigorous stirring. After mixing the 
reactants, the suspension was treated with ultrasound. 
Then, pH value was adjusted with 10 M NaOH to 
10.6 and the suspension was heated at 60 °C during 
10 min. After aging within 10 days the precipitate 
was thoroughly washed with the deionized water; 
solids were separated by centrifugation and steril-
ized. The degree of moisture in the obtained gel 
ranged from 70 to 88 w %. The composition of solids 
was: HA from 60 to 90 w %, AG from 10 to 40 w %. 
The obtained samples were dried at 37 °C and an-
nealed for 1 h at 900 °C for further research.
To evaluate the structure of samples – the lattice 
options (a, c), the average crystallite size (L, D) and 
microstrain ε – two methods were used and com-
pared: X-Ray diffraction (XRD) and transmission 
electron microscopy (TEM; SELMI, Sumy, Ukraine) 
with the electron diffraction (ED). The obtained data 
are shown in Table 2.
Both instrumental methods confirm the effect of 
the polymer component on the structural properties 
of HA crystallites. Thus, under the condition of syn-
thesis of HA nanoparticles in the presence of poly-
mer the size of crystallites decreased compared to 
pure HA in samples dried at 37 °C. An average size 
of crystallite increased after annealing and combus-
tion of the polymer component in the HA–CS and 
HA–AG samples. 
Fig. 5 shows the XRD patterns for the HA–CS 
and HA–AG samples dried at 37 °C and annealed at 
900 °C.
According to the XRD analysis, the sample 1 after 
annealing at 900 °C included two phases: HA 
(JCDPS 9-432, with 1.67 Ca / P ratio, concentration 
97 w %) and CaO (JCDPS 37-1497, concentration 
3 w %). The presence of another phase after the tem-
perature test indicates the nonstoichiometric output 
of apatite. The main factor causing a small size of 
crystallites and high level of microdeformations is 
an addition of chitosan, which, as has been shown in 
previous studies [55], reduces crystallinity of apatite 
and distorts its crystal lattice.
In the sample № 2 after annealing at 900 °C only 
one phase HA (JCPDS 9-432, with 1.67 Ca/P ratio) 
was found which indicated the stoichiometry of the 
initial apatite.
The nanostructures of the HA–CS and HA-AG 
composites were examined using TEM, as shown in 
our previous studies [56]. 
Table 2. Data of TEM and XRD analysis of structure of HA 
(pure), HA-CS and HA-AG composites
Sample
Dried at 37 oC Annealed at 900 ºC
TEM with ED XRD XRD
a, nm c, nm D, nm L, nm L, nm
HA-CS 0.949 0.688 ~80 14.3 55.4
HA-AG 0.945 0.688 ~80 24.6 58.6
HA 0.933 0.684 ~120 33.2 49.41
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Antibacterial properties of silver-doped 
HA-CS composites
One of the most important problems in modern im-
plantology is bacterial infection. The inflammation in 
the implant surrounding tissue eventually leads to the 
loss of the implant. The use of antimicrobial films or 
coatings is a way for preventing inflammation. 
Chitosan is one of the natural polysaccharides that can 
form a film with antibacterial properties. There are 
several mechanisms of antibacterial activity of chito-
san [47]. First, chitosan as a polycation forms electro-
static bonds with anionic molecules on the cell sur-
face and thereby affects their penetrating ability [57, 
58]. Second, chitosan binds to the negatively charged 
groups of DNA and thus inhibits the RNA synthesis 
[24, 59]. Finally, the antibacterial activity of chitosan 
can include both mechanisms, depending on the 
charge density in interacting components [24, 60]. 
Due to a large number of OH- and NH2-groups chito-
san can easily form chelates with metal ions [21, 61]. 
A)
Fig. 5. A) X-ray diffraction patterns of 
HA–CS nanocomposites dried at 37 °C 
and annealed for 1 h at 900 °С. ♦ – as-
signed CaO phase; B) X-ray diffraction 
patterns of HA-AG nanocomposites 
dried at 37 °C and annealed for 1 h at 
900 °С
B)
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Most silver-containing antimicrobial biomaterials 
consist of either Ag+ ions (silver salts or silver com-
plexes) or elemental silver (Ag-nanoparticles) incor-
porated into organic (polymers) or inorganic (bio-
glasses and HA) matrices [62, 63]. The silver-loaded 
HA composites are obtained by ion-exchange meth-
ods (sol-gel or coprecipitation) that involve the silver 
substitution for calcium, resulting in a Ca-deficient 
hydroxyapatite. The antimicrobial response of these 
materials is good, but there is pH-dependent negative 
rapid release of silver [64]. Silver nanoparticles have 
the antibacterial properties, delaying the growth of 
Gram-positive and Gram-negative bacteria. It is also 
well known that the antibacterial activity of Ag 
nanoparticles is caused not only by free Ag+ ions pro-
duced from nanoparticle surface but also by the inter-
action of small active nanoparticles with the microor-
ganisms cells and destruction of their membranes 
[65–67]. Chitosan-nanosilver-based films exhibit the 
excellent antibacterial activity against Escherichia 
coli [61]. Therefore, in the recent research [68], our 
group has used the termodeposition method [31] for 
obtaining antimicrobial Ag+-doped hydroxyapatite 
coatings under physiological conditions with various 
concentrations of silver ions and therefore different 
antibacterial activity. Thus, HA-Ag+-coatings were 
created on both the chitosan- modified and non-mod-
ified Ti-6Al-4V substrates. Antibacterial properties 
were studied by the optical density evaluation of the 
E.coli ATCC 25922 bacterial suspensions (Institute of 
Micro bio logy and Immunology, National Academy 
of Medical Sciences of Ukraine) before and after im-
mersing the experimental samples into these suspen-
sions. The optical density was measured by spectro-
photometry at l=540 nm 2, 24 and 48 h after the sam-
ple immersion. The bacterial cell amount was evalu-
ated from the optical density measurements of the 
bacteria suspension with known concentration in 
CFU mL-1 (Colony Forming Units). It was found that 
the inclusion of Ag+-ions into the coating significantly 
reduced the number of bacteria in a sample. Even a 
stronger effect occurred for the Ag+-ions doped HA 
coatings, formed at a surface of the substrate with CS 
layer (Fig. 6). 
The proposed approach can be taken as a promis-
ing method to create antimicrobial coatings for tita-
nium implants [68].
Chitosan-biopolymer composites for drug 
delivery
Regenerative medicine plays an important role in the 
restoring of damaged organs in vivo by the activation 
of stimulating factors of the organism. One of the 
advantages of chitosan is the ability of controlling 
the release of active compounds without the use of 
toxic organic solutions, because of its good solubili-
ty in weakly acid solutions. These circumstances led 
to the use of CS for the creation of drug delivery 
systems. For example, CS was once used for dis-
solving poorly soluble pharmaceuticals in the syn-
thesis of mucoadhesive mixtures [69–71], and for 
enhancement of the peptides absorption] [72–74]. 
Nowadays, various types of systems (tablets, cap-
sules, microspheres, nanoparticles, films, gels) are 
created using different methods (coating matrix, a 
capsule shell, emulsive cross-linking, coacervation/
precipitation, spray drying, ionic gelation, sieving 
method) [3]. The chosen method must be specific to 
the determined component in the particular case 
studied (particle size, thermal and chemical proper-
ties of active agents, the stability of the final pro-
Fig. 6. Dependence of E.coli growth on the time after immersion 
of HA–CS (modified substrate), HA–Ag (unmodified substrate) 
and HA–Ag (modified substrate) coatings in comparison with 
the HA coating
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duct, etc.). The main problem in the drug delivery 
therapy is to provide the necessary drug concentra-
tion at the destination [75]. One of the modern ap-
proaches is the use of CaP-biopolymer scaffolds, 
including polysaccharides of chitosan and alginate 
in combination with hydroxyapatite, as above dis-
cussed. It was shown that chitosan coatings on algi-
nate scaffolds enhance osteoblast adhesion and pro-
liferation [46]. Additionally, improvements in the 
composite mechanical properties were achieved in 
the scaffolds containing both polymers compared to 
those containing separate polysaccharides [76]. For 
example, the effectiveness of chitosan and alginate 
has been shown for more prolonged and controlled 
release of lidocaine (C14H22N2O), which is a local 
anesthetic drug, into physiological solution with 
phosphate buffer (PBS) [75]. According to FTIR 
spectroscopy, no chemical reactions have been reg-
istered between hydroxyapatite, chitosan, alginate 
and lidocaine. Instead, it has been shown that each 
polysaccharide affected crystal morphology of the 
drug: needle-shaped crystals of lidocaine occurred 
when chitosan was used as a coating, whereas the 
using alginate as a coating induced the formation of 
rectangular crystals [75].
Chitosan-metal complexes
As noted above, one of the important properties of 
chitosan is the formation of chelate with metal ions. 
Some researches prove a higher antimicrobial activ-
ity of chitosan-metal complexes compared with pure 
chitosan [77]. Such complexes were obtained in two 
stages. First, the nanoparticles of chitosan were pro-
duced by ionic gelation between chitosan and sodi-
um tripolyphosphate (Na5P3O10), then the obtained 
nanoparticles were connected (“loaded”) with metal 
ions (Ag+, Cu2+, Zn2+, Mn2+, Fe2+) [77]. Antibacterial 
activities of the metal ions doped chitosan nanopar-
ticles, pure chitosan nanoparticles, metal ions and 
1 w % acetic acid solution ( used as a solvent for 
chitosan) were evaluated by determination of the 
minimum inhibitory concentration (MIC) and mini-
mum bactericidal concentration (MBC). MIC was 
determined by the broth dilution method as an equiv-
alent to the minimum sample concentration that did 
not cause the visible bacteria growth in the tube, 
containing the bacteria suspension and experimental 
sample. To evaluate MBC, the bacteria suspension 
aliquot was transferred from each tube without visi-
ble growth on a Muller–Hinton (MH) agar plate 
(MH was used as a growth media) and incubated at 
37 oC for 24 h. MBC was determined as the mini-
mum sample concentration that did not cause any 
bacterial growth. Antibacterial properties of the chi-
tosan nanoparticles have been significantly improved 
by the metal ions addition. For example, for the Cu2+ 
doped CS-nanoparticles, MIC and MBC against 
E.coli ATCC25922, S.choleraesuis ATCC 50020 and 
S. aureus 25923 were 21-42 times lower than for 
pure Cu2+ ions [77]. The report states that Gram-
negative bacteria are more sensitive to chitosan-met-
al nanoparticles, due to a high negative charge at a 
surface of the respective cells, on the one hand, and 
a positive charge of amino groups reinforced by the 
interaction of macromolecules with metal ions, on 
the other hand. However, this hypothesis must be 
confirmed by new experimental and theoretical 
quantum-chemical researches.
Chitosan nanofibers
One of the newest applications of chitosan in medi-
cine is the development of natural methods for ob-
taining chitosan nanofibers [78]. Similar structures 
are produced by the “Nanospider” technology. The 
process occurs as follows. 1) In a special chamber 
between the cathode and anode a voltage of 60 kV is 
applied. 2) As a result, at a surface of the cathode 
covered with a thin film of chitosan solution, a spiral 
flow of polymer molecules is formed (Taylor cone). 
3) The velocity of the particles increases with the 
movement toward the negatively charged electrode; 
the diameter of individual flow reduces to nanoscale. 
4) Solvent molecules are evaporated and the 
stretched macromolecules are drawn together, i.e. a 
phase transition from liquid to solid state is observed. 
5) The obtained nanofibers are adsorbed to the nega-
tively charged base plate material (any substance, a 
metal substrate, etc.). 
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There are different physical, chemical (the type 
of solvent, the DD and MW parameters of chitosan, 
the solution homogenization without formation of 
macromolecular tangles, the viscosity and electri-
cal conductivity of the cathode forming solution) 
and technological (the humidity in the chamber 30-
50 w %, the distance between electrodes 150-
180 mm) features of this technology to vary for 
obtaining the chitosan nanofibers with a size of 70-
200 nm. The first attempts of application of the 
nanostructures, obtained by this technology, in 
medicine, e.g. as bandage, demonstrate a new per-
spective in the effective treatment of burns and 
similar injuries [78].
Conclusion
Chitosan characteristics considered in this review in-
dicate a significant potential for its use as a biomate-
rial with the required properties (porosity, degree of 
biodegradation) in the applied medicine, particularly 
for bone regeneration. However, some extra efforts 
are necessary to improve the mechanical properties 
of chitosan-based biomaterials for the applications. 
Another a very significant feature of chitosan is its 
ability of interacting with anionic biomolecules such 
as growth factors, glycosaminoglycans and DNA. 
The binding to DNA molecules makes it possible to 
obtain the material suitable for the application in 
gene therapy. Taking into account a combination of 
chitosan properties (biocompatibility, antibacterial 
ability, the complexation with growth factors and 
DNA) the conclusion can be made that chitosan is a 
very promising candidate for tissue engineering 
scaffolds. However, some parameters such as mo-
lecular weight, viscosity, should be further examined 
to exploit the potential of this natural polysaccharide 
in nanomedicine.
Acknowledgements
We thank the Ukrainian Fundamental Foundation 
(project NU/7-2013) for funding our researches, Dr. 
V.G. Lugin from State technological university of 
Belarus for IR-studies of the apatite-biopolymer 
samples.
REFERENCES
1. Jamalpoor Z. Chitosan: a brief review on structure and tis-
sue engineering application. J Appl Tissue Eng. 2014;1(1):3–
7.
2. Croisier F, Jerome C. Chitosan-based biomaterials for tis-
sue engineering. Eur Polym J. 2013;49(4):780–92.
3. Nikitenko P, Khrustitskaya L. Chitosan – a polymer of the 
future. The Science and Innovations. 2013;127(9):14–7.
4. Dash M, Chiellini F, Ottenbrite RM, Chiellini E. Chitosan – 
a versatile semi-synthetic polymer in biomedical applica-
tions. Prog Polym Sci. 2011;36(8):981–1014.
5. Di Martino A, Sittinger M, Risbud MV. Chitosan: a versatile 
biopolymer for orthopaedic tissue-engineering. Biomateri-
als. 2005;26(30):5983–90.
6. Mao JS, Cui YL, Wang XH, Sun Y, Yin YJ, Zhao HM, De Yao 
K. A preliminary study on chitosan and gelatin polyelectro-
lyte complex cytocompatibility by cell cycle and apoptosis 
analysis. Biomaterials. 2004;25(18):3973–81.
7. Jayakumar R, Menon D, Manzoor K, Nair SV, Tamura H. 
Biomedical applications of chitin and chitosan based nano-
materials. A short review. Carbohydr Polym. 2010;82(2): 
227–32.
8. Venkatesan J, Kim SK. Chitosan composites for bone tissue 
engineering – an overview. Mar Drugs. 2010;8(8):2252–66.
9. Dodane V, Vilivalam VD. Pharmaceutical applications of 
chitosan. Pharm Sci Technol Today. 1998;1(6):246–53.
10. Xie Y, Zhou NJ, Gong YF, Zhou XJ, Chen J, Hu SJ, Lu NH, 
Hou XH. Th immune response induced by H pylori vaccine 
with chitosan as adjuvant and its relation to immune protec-
tion. World J Gastroenterol. 2007;13(10):1547–53.
11. Dorozhkin SV. Nanodimensional and nanocrystalline apa-
tites and other calcium orthophosphates in biomedical engi-
neering, biology and medicine. Materials. 2009;2(4):1975–
2045.
12. Gomez L, Ramirez HL, Neira-Carrillo A, Villalonga R. 
Polyelectrolyte complex formation mediated immobiliza-
tion of chitosan-invertase neoglycoconjugate on pectin-
coated chitin. Bioprocess Biosyst Eng. 2006;28(6):387–95.
13. Madihally SV, Matthew HW. Porous chitosan scaffolds for 
tissue engineering. Biomaterials. 1999;20(12):1133–42.
14. Pavinatto FJ, Caseli L, Oliveira ON. Chitosan in nanostruc-
tured thin films. Biomacromolecules. 2010;11(8):1897–908.
15. Takahashi T, Takayama K, Machida Y, Nagai T. Character-
istics of polyion complexes of chitosan with sodium algi-
nate and sodium polyacrylate. Int J Pharm. 1990;61(1–
2):35–41.
16. Kim T-H, Jiang H-L, Jere D, Park I-K, Cho M-H, Nah J-W, 
Choi Y-J, Akaike T, Cho C-S. Chemical modification of chi-
tosan as a gene carrier in vitro and in vivo. Prog Polym Sci. 
2007;32(7):726–53.
17. Varum KM, Ottøy MH, Smidsrod O. Water-solubility of par-
tially N-acetylated chitosans as a function of pH: effect of 
95
Chitosan-apatite composites: synthesis and properties
chemical composition and depolymerisation. Carbohydr 
Polym. 1994;25(2):65–70.
18. Anthonsen MW, Smidsrod O. Hydrogen ion titration of chi-
tosans with varying degrees of N-acetylation by monitoring 
induced 1H-NMR chemical shifts. Carbohydr Polym. 1995; 
26(4):303–5.
19. Payne GF, Raghavan SR. Chitosan: a soft interconnect for 
hierarchical assembly of nano-scale components. Soft Mat-
ter. 2007;3(5):521–7.
20. Krajewska B. Application of chitin- and chitosan-based ma-
terials for enzyme immobilizations: a review. Enzyme Mi-
crob Technol. 2004;35(2–3):126–39.
21. Guibal E. Interactions of metal ions with chitosan-based 
sorbents: a review. Sep Purif Technol. 2004;38(1):43–74.
22. Chen AH, Yang CY, Chen CY, Chen CY, Chen CW. The 
chemically crosslinked metal-complexed chitosans for 
comparative adsorptions of Cu(II), Zn(II), Ni(II) and Pb(II) 
ions in aqueous medium. J Hazard Mater. 2009;163(2–
3):1068–75.
23. Kong M, Chen XG, Liu CS, Liu CG, Meng XH, Yu le J. An-
tibacterial mechanism of chitosan microspheres in a solid 
dispersing system against E. coli. Colloids Surf B Biointer-
faces. 2008;65(2):197–202.
24. Chung YC, Chen CY. Antibacterial characteristics and activ-
ity of acid-soluble chitosan. Bioresour Technol. 2008; 
99(8):2806–14.
25. Raafat D, von Bargen K, Haas A, Sahl HG. Insights into the 
mode of action of chitosan as an antibacterial compound. 
Appl Environ Microbiol. 2008;74(12):3764–73.
26. Seol YJ, Lee JY, Park YJ, Lee YM, Young-Ku, Rhyu IC, 
Lee SJ, Han SB, Chung CP. Chitosan sponges as tissue en-
gineering scaffolds for bone formation. Biotechnol Lett. 
2004;26(13):1037–41.
27. Seeherman H, Li R, Wozney J. A review of preclinical pro-
gram development for evaluating injectable carriers for os-
teogenic factors. J Bone Joint Surg Am. 2003;85-A Suppl 
3:96–108.
28. Zhang Y, Zhang M. Synthesis and characterization of macro-
porous chitosan/calcium phosphate composite scaffolds for 
tissue engineering. J Biomed Mater Res. 2001;55(3):304–12.
29. Zhang Y, Zhang M. Calcium phosphate/chitosan composite 
scaffolds for controlled in vitro antibiotic drug release. 
J Biomed Mater Res. 2002;62(3):378–86.
30. Lian Q, Li D, Jin Z, Wang J, Li A, Wang Z, Jin Z. Fabrication 
and in vitro evaluation of calcium phosphate combined with 
chitosan fibers for scaffold structures. J Bioactive Comp 
Polym. 2009;24(1):113–24.
31. Sukhodub LF, Yanovska GO, Sukhodub LB, Kuznetsov VM, 
Stanislavov OS. Nanocomposite apatite-biopolymer materi-
als and coatings for biomedical applications. J Nano- Elec-
tron Phys. 2014;6(1):id01001.
32. Swetha M, Sahithi K, Moorthi A, Srinivasan N, Ramasa-
my K, Selvamurugan N. Biocomposites containing natural 
polymers and hydroxyapatite for bone tissue engineering. 
Int J Biol Macromol. 2010;47(1):1–4.
33. Zhang Y, Zhang M. Three-dimensional macroporous calcium 
phosphate bioceramics with nested chitosan sponges for load-
bearing bone implants. J Biomed Mater Res. 2002;61(1):1–8.
34. Zhang Y, Ni M, Zhang M, Ratner B. Calcium phosphate-
chitosan composite scaffolds for bone tissue engineering. 
Tissue Eng. 2003;9(2):337–45.
35. Murugan R, Ramakrishna S. Bioresorbable composite bone 
paste using polysaccharide based nano hydroxyapatite. Bio-
materials. 2004;25(17):3829–35.
36. Wagoner Johnson AJ, Herschler BA. A review of the me-
chanical behavior of CaP and CaP/polymer composites for 
applications in bone replacement and repair. Acta Biomater. 
2011;7(1):16–30.
37. Klug HP, Alexander LE. X-Ray Diffraction procedures: for 
polycrystalline and amorphous materials. New York: Wiley, 
1974. 992 p.
38. Malesu VK, Sahoo D, Nayak PL. Chitosan–sodium alginate 
nanocomposites blended with cloisite 30b as a novel drug 
delivery system for anticancer drug curcumin. Int J Appl 
Biol Pharm. 2011;2(3):402–11.
39. Li B, Wang Y, Jia D, Zhou Y. Gradient structural bone-like 
apatite induced by chitosan hydrogel via ion assembly. 
J Biomater Sci Polym Ed. 2011;22(4–6):505–17.
40. Amaral IF, Granja PL, Barbosa MA. Chemical modification 
of chitosan by phosphorylation: an XPS, FT-IR and SEM 
study. J Biomater Sci Polym Ed. 2005;16(12):1575–93.
41. Roeges NPG. A Guide to the complete interpretation of in-
frared spectra of organic structures. Wiley: Chichester, 
1994. 340 p.
42. Tarasevich BN. IR spectra of major classes of organic com-
pounds. Moscow: Lomonosov Moscow State University, 
2012. 54 p.
43. Manjubala I, Scheler S, Bössert J, Jandt KD. Mineralisation 
of chitosan scaffolds with nano-apatite formation by double 
diffusion technique. Acta Biomater. 2006;2(1):75–84.
44. Rehman I, Bonfield W. Characterization of hydroxyapatite 
and carbonated apatite by photo acoustic FTIR spectrosco-
py. J Mater Sci Mater Med. 1997;8(1):1–4.
45. Nayar S, Sinha A. Systematic evolution of a porous hy-
droxyapatite-poly(vinylalcohol)-gelatin composite. Col-
loids Surf B Biointerfaces. 2004;35(1):29–32.
46. Han J, Zhou Z, Yin R, Yang D, Nie J. Alginate-chitosan/hy-
droxyapatite polyelectrolyte complex porous scaffolds: 
preparation and characterization. Int J Biol Macromol. 
2010;46(2):199–205.
47. Boddohi S, Moore N, Johnson PA, Kipper MJ. Polysaccha-
ride-based polyelectrolyte complex nanoparticles from chi-
tosan, heparin, and hyaluronan. Biomacromolecules. 2009; 
10(6):1402–9.
48. Ilina AV, Varlamov VP. Chitosan-based polyelectrolyte com-
plexes: a review. Appl Biochem Microbiol. 2005;41(1):5–11.
96
L. F. Sukhodub, L. B. Sukhodub, I. V. Chorna
49. Denuziere A, Ferrier D, Damour O, Domard A. Chitosan-
chondroitin sulfate and chitosan-hyaluronate polyelectro-
lyte complexes: biological properties. Biomaterials. 1998; 
19(14):1275–85.
50. Yin YJ, Yao KD, Cheng GX, Ma JB. Properties of polyelec-
trolyte complex films of chitosan and gelatin. Polym Int. 
1999;48(6):429–32.
51. Jiang T, Zhang Z, Zhou Y, Liu Y, Wang Z, Tong H, Shen X, 
Wang Y. Surface functionalization of titanium with chitosan/
gelatin via electrophoretic deposition: characterization and 
cell behavior. Biomacromolecules. 2010;11(5):1254–60.
52. Bhattarai N, Gunn J, Zhang M. Chitosan-based hydrogels 
for controlled, localized drug delivery. Adv Drug Deliv Rev. 
2010;62(1):83–99.
53. Drury JL, Mooney DJ. Hydrogels for tissue engineering: 
scaffold design variables and applications. Biomaterials. 
2003;24(24):4337–51.
54. Mann BK. Biologic gels in tissue engineering. Clin Plast 
Surg. 2003;30(4):601–9. 
55. Danilchenko SN, Kalinkevich OV, Kuznetsov VN, Kalinkev-
ich AN, Kalinichenko TG, Poddubny IN, Starikov VV, Sklyar 
AM, Sukhodub LF. Thermal transformations of the mineral 
component of composite biomaterials based on chitosan 
and apatite. Crystal Res Technol. 2010;45(7):685–91.
56. Kuznetsov VM, Sukhodub LB, Sukhodub LF. Structural and 
substructural features of apatite-biopolymer composites: the 
comparison of data obtained using X-ray diffraction and 
scanning electron microscopy with electron diffraction. 
J Nano- Electron Phys. 2014;6(4):id04039.
57. Je JY, Kim SK. Chitosan derivatives killed bacteria by dis-
rupting the outer and inner membrane. J Agric Food Chem. 
2006;54(18):6629–33.
58. Liu H, Du Y, Wang X, Sun L. Chitosan kills bacteria through 
cell membrane damage. Int J Food Microbiol. 2004; 
95(2):147–55.
59. Moussa SH, Tayel AA, Al-Turki AI. Evaluation of fungal chi-
tosan as a biocontrol and antibacterial agent using fluores-
cence-labeling. Int J Biol Macromol. 2013;54:204–8.
60. Chung YC, Su YP, Chen CC, Jia G, Wang HL, Wu JC, Lin 
JG. Relationship between antibacterial activity of chitosan 
and surface characteristics of cell wall. Acta Pharmacol Sin. 
2004;25(7):932–6.
61. Thomas V, Yallapu M, Mohan SB, Bajpai SK. Fabrication, 
characterization of chitosan. nanosilver film and its poten-
tial antibacterial application. J Biomater Sci Polym Ed. 
2009;20(14):2129–44.
62. Kumar R, Münstedt H. Silver ion release from antimicrobial 
polyamide/silver composites. Biomaterials. 2005;26(14): 
2081–8.
63. Alt V, Bechert T, Steinrücke P, Wagener M, Seidel P, Dingel-
dein E, Domann E, Schnettler R. An in vitro assessment of the 
antibacterial properties and cytotoxicity of nanoparticulate 
silver bone cement. Biomaterials. 2004;25(18):4383–91.
64. Han IH, Lee IS, Song JH, Lee MH, Park JC, Lee GH, Sun 
XD, Chung SM. Characterization of a silver-incorporated 
calcium phosphate film by RBS and its antimicrobial ef-
fects. Biomed Mater. 2007;2(3):S91–4.
65. Diaz M, Barba F, Miranda M, Guiti F, Torrecillas R, Moya JS. 
Synthesis and Antimicrobial Activity of a Silver-Hydroxyapa-
tite Nanocomposite. J Nanomater. 2009;2009:id498505.
66. Rai M, Yadav A, Gade A. Silver nanoparticles as a new gen-
eration of antimicrobials. Biotechnol Adv. 2009;27(1):76–83.
67. Bragg PD, Rainnie DJ. The effect of silver ions on the re-
spiratory chain of Escherichia coli. Can J Microbiol. 
1974;20(6):883–9.
68. Yanovska AA, Stanislavov AS, Sukhodub LB, Kuznetsov VN, 
Illiashenko VYu, Danilchenko SN, Sukhodub LF. Silver-
doped hydroxyapatite coatings formed on Ti-6Al-4V sub-
strates and their characterization. Mater Sci Eng C Mater 
Biol Appl. 2014;36:215–20.
69. Miyazaki S, Ishii K, Nadai T. The use of chitin and chitosan 
as drug carriers. Chem Pharm Bull (Tokyo). 1981;29(10): 
3067–9.
70. He P, Davis SS, Illum L. Chitosan microspheres prepared by 
spray drying. Int J Pharm. 1999;187(1):53–65.
71. Sawayanagi Y, Nambu N, Nagai T. Dissolution properties and 
bioavailability of phenytoin from ground mixtures with chitin 
or chitosan. Chem Pharm Bull (Tokyo). 1983;31(6):2064–8.
72. Illum L, Farraj NF, Davis SS. Chitosan as a novel nasal deliv-
ery system for peptide drugs. Pharm Res. 1994;11(8):1186–9.
73. Luessen HL, Lehr CM, Rentel CO, Noach ABJ, de Boer AG, 
Verhoef JC, Junginger HE. Bioadhesive polymers for the 
peroral delivery of peptide drugs. J Controlled Release. 
1994;29(3):329–38.
74. Artursson P, Lindmark T, Davis SS, Illum L. Effect of chito-
san on the permeability of monolayers of intestinal epithe-
lial cells (Caco-2). Pharm Res. 1994;11(9):1358–61.
75. Dubnika A, Loca D, Berzina-Cimdina L. Functionalized hy-
droxyapatite scaffolds coated with sodium alginate and chi-
tosan for controlled drug delivery. Proc Estonian Acad Sci. 
2012;61(3):193-9.
76. Li Z, Ramay HR, Hauch KD, Xiao D, Zhang M. Chitosan-
alginate hybrid scaffolds for bone tissue engineering. Bio-
materials. 2005;26(18):3919–28.
77. Du WL, Niu SS, Xu YL, Xu ZR, Fan CL. Antibacterial activ-
ity of chitosan tripolyphosphate nanoparticles loaded with 
various metal ions. Carbohydr Polym. 2009;75(3):385–9.
78. Ifuku S. Chitin and chitosan nanofibers: preparation and 
chemical modifications. Molecules. 2014;19(11):18367–80.
Хітозан-апатитні композити: синтез і властивості 
Л. Ф. Суходуб, Л. Б. Суходуб, І. В. Чорна
Мета цього короткого огляду – розгляд застосування унікаль-
ного біополімеру хітозану в практичній медицині, особливо 
для інженерії кісткової тканини. Основне місце в статті відве-
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дено синтезу та властивостям інноваційних біоматеріалів на 
основі хітозану, таким як CaP-хітозан (CS-CP)-композити і хі-
тозан-альгінатні (CS-AG)-скаффолди. У статті висвітлено фі-
зико-хімічні властивості, спектральні характеристики і хімічні 
модифікації молекули хітозану. Отримані хітозан-апатитні 
композитні матеріали були проаналізовані з використанням 
методу рентгенівської дифракції для аналізу кристалічної при-
роди їх структур. Було виявлено, що додавання хітозану до 
композитного матеріалу призводить до зниження кристаліч-
ності вихідного апатиту. Крім того, акцентовано увагу на анти-
бактеріальні властивості хітозану, використанні наночастинок 
хітозану для отримання нановолокон і створенні системи 
контрольованої доставки ліків. 
К л юч ов і  с л ов а: хітозан, гідроксиапатит, біокомпозити, 
рентгенівська дифракція.
Хитозан-апатитные композиты: синтез и свойства
Л. Ф. Суходуб, Л. Б. Суходуб, И. В. Черная
Цель этого краткого обзора – рассмотрение применения уни-
кального биополимера хитозана в практической медицине, 
особенно для инженерии костной ткани. Основное место в 
стать е отведено синтезу и свойствам инновационных биомате-
риалов на основе хитозана, таким как CaP-хитозан (CS-CP)-
композиты и хитозан-альгинатные (CS-AG)-скаффолды. 
В статье освещены физико-химические свойства, спектраль-
ные характеристики и химические модификации молекулы 
хитозана. Полученные хитозан-апатитные композитные мате-
риалы были проанализированы с использованием метода рент-
геновской дифракции для анализа кристаллической природы 
их структур. Было обнаружено, что добавление хитозана к 
композитному материалу приводило к снижению кристаллич-
ности исходного апатита. Кроме того, акцентировано внима-
ние на антибактериальных свойствах хитозана, использовании 
наночастиц хитозана для получения нановолокон и создании 
систем контролируемой доставки лекарств.
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